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Abstract 
Review on SREBF1, with data on DNA, on the 
protein encoded and where the gene is implicated. 
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Identity 
Other names: SREBP1, bHLHd1, SREBP-1c, 
SREBP1a 
HGNC (Hugo): SREBF1 
Location: Located on 17p11.2 
Local order 
SREBF1 spans 26,619 bp, starts at 17811349 and 




Orientation: Minus strand; 25669 bp; Exon count: 
22; intron count: 20 
Transcription 
SREBF1 gene has 23 transcripts (Table 1) 
Figure 1. Gene neighbours of LIPE on chromosome 17p11.2 (Chromosome 17 - NC_000017.11 Reference: GRCh38.p12 
current assembly, NCBI Annotation Release 109). 
Figure 2. Genomic organization of the SREBF1 gene. Exons are numbered indicating the alternatively spliced a' and c' variants 
(adapted from Kedenko et al., 2012). 
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Name   Transcript ID   bp   Protein   Biotype   
SREBF1-201   ENST00000261646.9   4178   1147   
Protein 
coding   
SREBF1-202   ENST00000355815.8   4253   1177   
Protein 
coding   
SREBF1-203   ENST00000395751.8   4653   216   
Nonsense 
mediated 
decay   
SREBF1-204   ENST00000395756.5   3026   113   
Nonsense 
mediated 
decay   
SREBF1-205   ENST00000395757.5   3696   893   
Protein 
coding   
SREBF1-206   ENST00000423161.3   1058   325   
Protein 
coding   
SREBF1-207   ENST00000447641.5   644   
No 
protein   
Retained 
intron    
SREBF1-208   ENST00000469356.3   1323   
No 
protein   
Retained 
intron    
SREBF1-209   ENST00000470247.1   374   
No 
Protein   
Retained 
intron    
SREBF1-210   ENST00000471445.5   936   
No 
protein   
Retained 
intron    
SREBF1-211   ENST00000476994.1   591   
No 
protein   
Retained 
intron    
SREBF1-212   ENST00000478616.1   882   163   
Protein 
coding   
SREBF1-213   ENST00000485080.6   1230   110   
Nonsense 
mediated 
decay   
SREBF1-214   ENST00000486311.5   473   157   
Protein 
coding   
SREBF1-215   ENST00000487401.1   477   
No 
protein   
Retained 
intron    
SREBF1-216   ENST00000490796.1   698   
No 
protein   
Retained 
intron    
SREBF1-217   ENST00000577897.1   536   66   
Protein 
coding   
SREBF1-218   ENST00000578469.1   588   31   
Protein 
coding   
SREBF1-219   ENST00000580540.1   540   
No 
protein   
Retained 
intron    
SREBF1-220   ENST00000581707.1   695   
No 
protein   
Retained 
intron    
SREBF1-221   ENST00000583080.1   482   
No 
protein   
Retained 
intron    
SREBF1-222   ENST00000583732.1   580   
No 
protein   
Processed 
transcript   
SREBF1-223   ENST00000584760.1   564   
No 
protein   
Retained 
intron    
Table 1. Transcripts of human SREBF1 gene (Ensembl 
annotation Release 85).   
Protein 
SREBF1 gene encodes 1147 amino acid sized 
protein which has 121675 Da molecular mass. 
SREBF1 is helix-loop-helix transcriptional activator 
required for lipid homeostasis (Figure 3). Regulates 
transcription of the LDL receptor gene as well as the 
fatty acid and cholesterol synthesis pathways. Binds 
to the sterol regulatory element 1 (SRE-1) (5'-
ATCACCCCAC-3'). Has dual sequence specificity 
binding to both an E-box motif (5'-ATCACGTGA-
3') and to SRE-1 (5'-ATCACCCCAC-3'). 
 
Figure 3. Co-crystal structure of sterol regulatory element 
binding protein 1a bound to an LDL Receptor promoter at 
2.3 A resolution (adapted from Párraga et al., 1998). 
Description 
The encoded protein is synthesized as a precursor 
that is initially attached to the nuclear membrane and 
endoplasmic reticulum. After cleavage, the mature 
protein translocates to the nucleus and activates 
transcription. This cleaveage is inhibited by sterols. 
Alternative promoter usage and splicing result in 
multiple transcript variants. 6 isoforms are 
described. Isoform 1A has been choosen as the 
canonical sequence (provided by RefSeq, Nov 
2017). Quaternary structure of protein forms a tight 
complex with SCAP in the ER membrane. Efficient 
DNA binding of the soluble transcription factor 
fragment requires dimerization with another bHLH 
protein. Interacts with LMNA. Interacts with 
CEBPA, the interaction produces a transcriptional 
synergy (By similarity).  
Post-translational modifications:   
At low cholesterol the SCAP/SREBP complex is 
recruited into COPII vesicles for export from the ER. 
In the Golgi complex SREBPs are cleaved 
sequentially by site-1 and site-2 protease. The first 
cleavage by site-1 protease occurs within the luminal 
loop, the second cleavage by site-2 protease occurs 
within the first transmembrane domain and releases 
the transcription factor from the Golgi membrane. 
Apoptosis triggers cleavage by the cysteine 
proteases CASP3 and CASP7 (caspase-3 and 
caspase-7).  
Phosphorylated by AMPK (Protein kinase AMP-
activated catalytic subunits), leading to suppress 
protein processing and nuclear translocation, and 
repress target gene expression. Phosphorylation at 
Ser-402 by SIK1 represses activity possibly by 
inhibiting DNA-binding.  
Ubiquitinatylated at Lys347, Lys379, Lys587, 
Lys675, Lys934, Lys1070. 
Expression 
Expressed in a wide variety of tissues, most 
abundant in fat and adrenal gland. In fetal tissues, 
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lung and liver shows highest expression. Isoform 
SREBF-1C predominates in liver, adrenal gland and 
ovary, whereas isoform SREBF-1A predominates in 
hepatoma cell lines. Isoform SREBF-1A and 
isoform SREBF-1C are found in kidney, brain, white 
fat, and muscle. 
Localisation 
Endoplasmic reticulum membrane, golgi membrane, 
nuclear envelope, nucleoplasm, nucleus, COPII - 
coated vesicle membrane. 
Function 
SREBF1 Transcription factor binds to the sterol 
regulatory element-1 (SRE1) (5-ATCACCCCAC-3) 
which is a motif found in the promoter of the low 
density lipoprotein receptor genes and other genes 
that involved in sterol biosynthesis.  
Depletion of cholesterol leads to intra-membrane 
proteolysis, releasing the active portion of SREBF1 
containing the basic DNA-binding region from the 
endoplasmic reticulum membrane.  
After translocation to the nucleus and binding to its 
specific DNA sequences, SREBF1 dimers induce the 
expression of target genes involved in adipogenesis 
and membrane biogenesis (Nohturfft and Zhang, 
2009). 
Homology 
SREBF1 gene is conserved in chimpanzee, Rhesus 
monkey, dog, cow, mouse, rat, chicken, zebrafish, 
fruit fly, mosquito and frog (Table 2).  
Gene Identity %& 
Species   Symbol    Protein   DNA   
H. Sapiens   SREBF1         
vs. P.troglodytes   SREBF1   98.7   99.0   
vs. M.mulatta    SREBF1   97.5   97.1   
vs. C.lupus   SREBF1   87.9   87.2   
vs. B.taurus   SREBF1   84.5   85.8   
vs. M.musculus   Srebf1   81.2   80.9   
vs. R.norvegicus   Srebf1   81.6   82.0   
vs.  G.gallus    SREBF1   65.8   69.5   
vs. X.tropicalis    srebf1   67.0   65.9   
vs D.reriro   srebf1   61.3   62.4   
vs D.melanogaster   HLH106   37.5   48.4   
vs. A.gambiae   AgaP_AGAP000076   39.2   49.7   
Table 2. Pairwise alignment of SREBF1 gene and protein 
sequences (in distance from human). 
Mutations 
304 missense, 36 truncating and 3 inframe and 7 
other mutations of SREBF1 was identified in 74247 
samples from 240 studies (cBioPortal) (Figure 4). 
Somatic 
4 SNPs were registered for SREBF1 (according to 
SNPedia and Human Gene Mutation Database). 
Implicated in 
Endometrial Cancer (EC) 
Higher level of SREBF1 has been detected in EC 
cells compared to the normal endometrium, and 
which was more prominent in higher-grade EC. NP 
(rs2297508) of SREBF-1 may serve as a genetic 
predisposition factor for the development of EC Qui 
et al., 2014). 
Pancreatic Cancer 
SREBF1 is highly expressed in pancreatic ductal 
cancer. The expression of SREBF1 is an independent 
risk factor affecting the overall survival of patients 
with pancreatic cancer (Sun et al., 2015. 
Hepatocellular Carcinoma (HCC) 
SREBF1 expression is activated in HCC. 
Suppression of SREBF1 induced growth arrest and 
apoptosis whereas overexpression of SREBF1 
enhanced cell proliferation in human HCC cell lines. 
There are a significant relationship between poor 
survival and high SREBF1 protein expression and 
correlation between high SREBF1 protein 
expression and high risk of mortality with statistical 
significance (Yamashita et al., 2008). 
Ovarian Cancer 
SREBF1 protein expression was significantly higher 
in human ovarian cancer compared to benign and 
borderline ovarian tumors (Nie et al., 2013). 
Breast cancer 
mRNA levels for SREBF-1c increase in a panel of 
primary human breast cancer samples (Yang et al., 
2003). 
Colorectal Carcinoma 
SREBF1 and FAS expression upregulated in 
colorectal carcinoma cells. It was hypothesized that, 
tumor cells recognize and respond to a deficiency in 
endogenous fatty acid synthesis by upregulating both 
SREBF1 and FAS expression and these findings 
support the model that SREBF1 participates in the 
transcriptional regulation of lipogenic genes in 
colorectal neoplasia (Li et al., 2000). 
Obesity and Obesity-related 
metabolic traits; Type 2 diabetes and 
Dyslipidemia 
The SREBF1 molecular screening of 40 unrelated 
obese patients revealed 19 single nucleotide 
polymorphisms (SNPs).  
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Figure 4.  Mutation types observed in SREBF1 expression in literature and corresponding color codes are as follows: Green: 
Missense Mutations ; Black: Truncating Mutations: Nonsense, Nonstop, Frameshift deletion, Frameshift insertion, Splice site; 
Beige: In-frame Mutations: In-frame deletion, In-frame insertion ; Purple: Other Mutations: All other types of mutations. 
 
SNP17 (54G/C, exon 18c) is associated with morbid 
obesity. SNP3 (-150G/A, exon 1a), SNP5 (-36delG, 
exon 1a), and SNP17 are found in high linkage 
disequilibrium (D' > 0.8). The haplotype including 
wild-type alleles of these SNPs (C/G/G/T/C/G, 
HAP2) is identified as a risk factor for morbid 
obesity (P = 0.003).  
In the obese group, SNP3, SNP5, and SNP17 are 
associated with male-specific hypertriglyceridemia 
(P = 0.07, P = 0.01, and P = 0.05, respectively). 
SNP17 is also associated with type 2 diabetes (P = 
0.03) (Eberlé et al., 2004). In addition, it was shown 
that insulin induces SREBF1 gene expression in 
isolated human adipocytes and skeletal muscle and 
also promotes SREBF1 cleavage in human isolated 
adipocytes. Common insulin-resistant states, such as 
obesity and type 2 diabetes, are characterized by 
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